19. Moderna, Inc. (NASDAQ:MRNA)
Moderna, Inc. (NASDAQ:MRNA) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer highlighted the stock’s significant gains during the year, as he said:
If you look at the market’s best performers year to date, nearly all of them are either companies that sell hardware into the data center or companies that sell hardware to the hardware makers. But there’s one solitary exception in the top 15: Moderna, the biotech company best known for its COVID vaccine. Right now, Moderna’s the 12th best-performing stock in the S&P 500, up 146% year to date. Now, that is pretty impressive… The truth is, after spending years lost in the post-COVID wilderness, this company’s now got a lot going for it. I think the rally’s for real. I think the company’s for real now…
It’s no wonder that Moderna stock has caught fire; think about all these great things they’re doing. For the first time in a long time, the company seems like it is something to get excited about in the not too distant future. But, and this is a big but, let’s not forget that Moderna’s still losing money. In fact, they don’t expect to reach cash break-even levels until 2028. Actual earnings per share likely won’t turn positive until 2029. But the company is at last beginning to realize its true potential. Plus, while I found Moderna’s cancer trials very impressive, these are basically just cancer treatments. They’re not the personalized anti-cancer vaccines that management’s been talking about for years that got me so excited about the stock…
Let me give you the bottom line on this amazing story that wasn’t amazing for a long time: Even though Moderna’s still early on its turnaround, it’s hard not to be excited about what the company presented just last week. Moderna’s got a plethora of thoughtful new products and a clear roadmap to profitability for the first time in such a long time. Honestly, now, look, I am a bit wary of chasing any stock that’s up nearly 150%, but the truth is Moderna finally feels investible again. That said, I recommend waiting for a pullback, there probably will be one, before you buy. Take your time. I think Moderna’s got a bright future, though. It’ll take years to get there… For the first time in ages, I like having a position in Moderna.
Moderna, Inc. (NASDAQ:MRNA) makes mRNA medicines and vaccines to protect against illnesses like the flu, COVID-19, and some other viruses. The company also works on treatments for cancer and rare diseases.
